Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)
Others
Ratios

Creative Medical Technology Holdings (CELZ) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for Creative Medical Technology Holdings (CELZ) over the last 17 years, with Q3 2025 value amounting to $31059.0.

  • Creative Medical Technology Holdings' Other Operating Expenses rose 610.84% to $31059.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $115017.0, marking a year-over-year increase of 148.5%. This contributed to the annual value of $110452.0 for FY2024, which is 1677.66% up from last year.
  • Per Creative Medical Technology Holdings' latest filing, its Other Operating Expenses stood at $31059.0 for Q3 2025, which was up 610.84% from $30742.0 recorded in Q2 2025.
  • Creative Medical Technology Holdings' Other Operating Expenses' 5-year high stood at $31059.0 during Q3 2025, with a 5-year trough of $22639.0 in Q4 2024.
  • For the 5-year period, Creative Medical Technology Holdings' Other Operating Expenses averaged around $25346.4, with its median value being $23021.0 (2021).
  • In the last 5 years, Creative Medical Technology Holdings' Other Operating Expenses skyrocketed by 3970.75% in 2021 and then crashed by 1129.27% in 2024.
  • Quarter analysis of 5 years shows Creative Medical Technology Holdings' Other Operating Expenses stood at $23021.0 in 2021, then changed by 0.0% to $23021.0 in 2022, then rose by 10.86% to $25521.0 in 2023, then fell by 11.29% to $22639.0 in 2024, then soared by 37.19% to $31059.0 in 2025.
  • Its Other Operating Expenses was $31059.0 in Q3 2025, compared to $30742.0 in Q2 2025 and $30577.0 in Q1 2025.